BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10707823)

  • 1. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
    Pechánová O; Bernátová I; Babál P
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I; Pechánová O; Simko F
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
    Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The stereology of the myocardium in rats hypertensive due to the use of an inhibitor of nitric oxide synthesis].
    Pereira LM; Mandarim-de-Lacerda CA
    Rev Port Cardiol; 1997 Oct; 16(10):753-9, 743. PubMed ID: 9479938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term administration of D-NAME induces hemodynamic and structural changes in the cardiovascular system.
    Babál P; Pechánová O; Bernátová I
    Physiol Res; 2000; 49(1):47-54. PubMed ID: 10805404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies.
    Buhimschi IA; Shi SQ; Saade GR; Garfield RE
    Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
    J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats.
    Afkir S; Nguelefack TB; Aziz M; Zoheir J; Cuisinaud G; Bnouham M; Mekhfi H; Legssyer A; Lahlou S; Ziyyat A
    J Ethnopharmacol; 2008 Mar; 116(2):288-95. PubMed ID: 18191352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
    Kopincova J; Puzserova A; Bernatova I
    Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nitric oxide synthase--versus lipoxygenase inhibition on coronary flow and nitrite outflow in isolated rat heart.
    Jakovljevic VLj; Djuric DM
    Gen Physiol Biophys; 2005 Jun; 24(2):199-207. PubMed ID: 16118472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged inhibition of nitric oxide synthesis in pregnant rats: effects on blood pressure, fetal growth and litter size.
    Fernández Celadilla L; Carbajo Rueda M; Muñoz Rodríguez M
    Arch Gynecol Obstet; 2005 Mar; 271(3):243-8. PubMed ID: 15791477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.